A major shift in Delaware pharmacy law lets pharmacists prescribe independently—and most health service owners haven't heard about it yet.
Most Delaware health service owners don't realize that pharmacists in their state now have independent prescriptive authority. That's the buried provision in SB320, An Act To Amend Title 16 And Title 24 Of The Delaware Code Relating To Pharmacy And Pharmacists. And if you own or operate a pharmacy, clinic, or related health service, it changes your business model.
Under Section 5, § 2566 (new Subchapter VIII) of SB320, Delaware pharmacists can now prescribe certain drugs and devices directly to patients without a physician's order or oversight. This is a significant expansion of scope of practice. Previously, pharmacists operated under physician supervision for most prescriptive decisions. Now, within defined parameters, they can initiate therapy independently.
The law takes effect immediately upon enactment. Implementation—including Board of Pharmacy registration and compliance protocols—must be completed no later than one year from enactment or upon Board of Pharmacy publication of final rules, whichever comes first.
New Revenue Streams: Independent pharmacist prescribing creates billable services that didn't exist before. Pharmacies can now charge for consultations, assessments, and prescriptions that previously required a physician referral. For small independent pharmacies especially, this can open a direct-to-patient revenue channel.
New Costs and Compliance Burdens: The upside comes with operational requirements. You'll need to:
These aren't trivial expenses. Insurance premiums, compliance software, staff training, and legal review all carry direct costs. You'll also need to decide whether your operation is positioned to take on prescriptive liability.
Independent pharmacies and small health service networks are the primary targets of this change. Larger chains may already have compliance infrastructure in place. But if you run a standalone pharmacy or a small multi-location operation, you're now facing a decision: invest in the systems and insurance to offer independent prescribing, or maintain the status quo.
Clinics, urgent care centers, and other health services that employ or contract with pharmacists should also review their agreements and liability coverage in light of this change.
Don't wait for Board of Pharmacy rules to finalize. Start now by:
SB320 is real, it's law, and the clock is running. The decision to participate is yours—but it needs to be made with full understanding of both the opportunity and the cost.
Source: Delaware SB320, Section 5, § 2566 (new Subchapter VIII); effective upon enactment with implementation required no later than one year from enactment or upon Board of Pharmacy publication of rules.